Skip to Content

Sodium hyaluronate Pregnancy and Breastfeeding Warnings

Sodium hyaluronate is also known as: Durolane, Euflexxa, Gelsyn-3, Hyalgan, Supartz, Supartz FX

Medically reviewed on March 27, 2018

Sodium hyaluronate Pregnancy Warnings

Sodium hyaluronate has not been formally assigned to a pregnancy category by the FDA. Animal studies have failed to reveal evidence of fertility impairment or teratogenicity. There are no controlled data in human pregnancy. Sodium hyaluronate is only recommended for use during pregnancy if benefit outweighs risk.

See references

Sodium hyaluronate Breastfeeding Warnings

There are no data on the excretion of sodium hyaluronate into human milk.

See references

References for pregnancy information

  1. "Product Information. Hyalgan (hyaluronidate sodium)." Sanofi Winthrop Pharmaceuticals, New York, NY.

References for breastfeeding information

  1. "Product Information. Hyalgan (hyaluronidate sodium)." Sanofi Winthrop Pharmaceuticals, New York, NY.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide